Treatment with intravenous bisphosphonates — drugs used to reduce harm done to bones by cancer or cancer therapy — increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found.
Studies show that the incidence of mental illness on college campuses is rising, and a new survey of 2,785 college students indicates that more than half of students with significant symptoms of anxiety or depression do not seek help.
It is estimated that between 10 and 17% of the population has suffered tinnitus at some time in their lives, according to a number of international studies. Tinnitus is understood as the perception of noise in the ears or inside the head although there is no external source of sound, without any vibratory cochlear activity taking place (which occurs when an external noise is produced). Depending on the intensity of the symptom, the patient may have their everyday life affected. In extreme cases the discomforts may make working routines impossible or negatively affect normal daily life.
In this week’s PLoS Medicine, Nathan Ford and colleagues from the humanitarian agency M?decins Sans Fronti?res (MSF; Doctors Without Borders) describe their experience of providing HIV prevention and treatment in two prisons in Thailand.
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.
Researchers at the Picower Institute at MIT have, for the first time, reversed symptoms of mental retardation and autism in mice. The study may lead to new drug therapies for a leading inherited cause of mental retardation (Fragile X Syndrome) and some types of autism.
Cyclical, long-term estrogen injections protected brain cells from age-related deterioration, according to a new study conducted at Mount Sinai School of Medicine. The study suggests that age is a factor in estrogen treatment and sheds light on the intricate relationship between mind, age, and hormones. The study will be published in the online edition of Proceedings of the National Academy of Sciences during the week of June 25.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced study results comparing treatment with BYETTA(R) (exenatide) injection with insulin glargine in people with type 2 diabetes.
The first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease is completed by a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Novo Nordisk (NYSE:NVO) has announced results of a new study that further demonstrated the safety and efficacy of insulin Levemir? (insulin detemir [rDNA origin] injection).